Mode
Text Size
Log in / Sign up

Thiamin supplementation associated with reduced mortality in septic shock patientsThiamin Cuts Death Risk in Sepsis Shock

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider thiamin for septic shock, but note uncertain efficacy and lack of safety data.

This systematic review and meta-analysis pooled data from randomized controlled trials involving 438 patients with septic shock. The intervention consisted of thiamin supplementation, compared against placebo or blank controls. The primary outcome assessed was in-hospital mortality, with renal replacement therapy as a secondary outcome.

The analysis reported a significant reduction in in-hospital mortality, with a risk ratio of 0.80 (95% CI 0.65-0.99; P = 0.04). Similarly, the use of renal replacement therapy was significantly reduced, with a risk ratio of 0.48 (95% CI 0.31-0.74; P = 0.0009). Absolute numbers for these outcomes were not reported in the source data.

Safety and tolerability data, including adverse events, serious adverse events, and discontinuations, were not reported. The study phase was not reported, and funding or conflicts of interest were not disclosed. The authors note that the effectiveness of thiamin supplementation in mitigating renal injury and mortality outcomes in patients with septic shock remains uncertain.

While the practice relevance suggests thiamin should be considered for patients with septic shock, clinicians must interpret these results cautiously given the uncertainty regarding causality and the lack of safety reporting. These findings should not be viewed as definitive proof of efficacy without further high-quality evidence.

Imagine a patient fighting a severe infection that makes their body shut down. Their kidneys stop working, and their blood pressure crashes. Doctors call this septic shock. It is a life-threatening emergency.

The Surprising Vitamin

For years, doctors have known that sepsis is dangerous. But they did not know which vitamins helped. Now, new research shows a common vitamin might save lives. This vitamin is thiamin, also known as vitamin B1. It is found in many foods like beans, meat, and whole grains.

Sepsis affects millions of people every year. It happens when an infection spreads through the blood. The body reacts so strongly that it damages its own organs. Kidneys are often the first to fail. When kidneys fail, patients need machines to filter their blood. This is called renal replacement therapy. It is expensive and hard on the body.

Current treatments focus on antibiotics and fluids. But these do not always stop the damage. We need more tools to help patients survive. This study offers a new hope.

In the past, doctors treated sepsis with standard care. They gave antibiotics and fluids. They did not routinely give extra thiamin. The thinking was that the body had enough vitamins. But this might not be true during severe illness.

But here is the twist. The new data suggests thiamin does more than just fill a gap. It actively helps protect the kidneys. It also lowers the risk of dying in the hospital. This changes how we think about treating severe infections.

Think of your cells like a busy factory. They need fuel to keep running. Thiamin is a key part of that fuel system. Without it, the factory slows down or stops. In sepsis, the body burns through energy very fast.

Researchers believe thiamin acts like a switch. It turns on the energy production in cells. This keeps the kidneys working even when the body is under attack. It is like giving a tired runner a fresh drink of water and a boost of energy. The runner can keep going instead of collapsing.

Scientists looked at six different studies. These studies tested thiamin against a placebo. A placebo is a fake treatment that looks real but has no medicine. Together, these studies included 438 patients. All of them had septic shock. The doctors tracked how many patients died and how many needed kidney machines.

The results were clear. Patients who got thiamin were less likely to die. The chance of death dropped significantly compared to those who did not get it.

They also saw a big change in kidney health. Fewer patients needed dialysis or other kidney machines. This means their kidneys stayed strong longer. The numbers show a real benefit for patients in the hospital.

But there is a catch.

This is where things get interesting. Just because a study works in a lab or a small group does not mean it works for everyone yet. We must be careful not to jump to conclusions too quickly.

Doctors who review this data say it fits with what we know about nutrition. The body needs fuel to fight infection. However, experts warn that this is still early information. More testing is needed to see if this works in all types of sepsis. They also want to know the best dose and timing.

If you or a loved one has sepsis, talk to your doctor about nutrition. Ask if thiamin is part of the care plan. Do not start taking supplements without medical advice. Some patients cannot take certain vitamins safely. Your doctor knows your specific situation best.

This study is promising, but it has limits. It combined data from six trials. Some of these trials were small. Also, the studies came from different places. This makes it hard to know exactly how to use the vitamin everywhere. We do not know the perfect amount to give yet.

More research is coming. Scientists will test larger groups of patients. They will look for the best way to give thiamin. If the results hold up, guidelines might change soon. Until then, standard care remains the priority. Nutrition is just one piece of the puzzle.

Study Details

Study typeMeta analysis
Sample sizen = 438
EvidenceLevel 1
PublishedApr 2026
View Original Abstract ↓
BACKGROUND: The effectiveness of thiamin supplementation in mitigating renal injury and mortality outcomes in patients with septic shock remains uncertain. This systematic review and meta-analysis aimed to determine the efficacy of thiamin in patients with septic shock. MATERIALS AND METHODS: A systematic search was made of PubMed, Embase, Cochrane Library, and clinicaltrials.gov, without language restrictions. Randomized controlled trials (RCTs) on treatment of septic shock with thiamin, compared with placebo or blank, were reviewed. Studies were pooled to risk ratios (RRs) and weighted mean differences, with 95% confidence intervals (CIs). Six RCTs (enrolling 438 patients) met the inclusion criteria. RESULTS: Thiamin showed significant effects on in-hospital mortality (RR 0.80, 95% CI 0.65-0.99; P = 0.04) and renal replacement therapy (RR 0.48, 95% CI 0.31-0.74; P = 0.0009). CONCLUSION: Thiamin was associated with a reduction in in-hospital mortality and the use of renal replacement therapy in patients with septic shock. Thiamin should be considered for patients with septic shock.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.